OrbiMed’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $47.5M | Buy |
|
|||||
|
2024
Q2 | $24M | Hold |
|
|||||
|
2024
Q1 | $21.9M | Buy |
|
|||||
|
2023
Q4 | $11.9M | Hold |
|
|||||
|
2023
Q3 | $11.1M | Hold |
|
|||||
|
2023
Q2 | $9.7M | Sell |
|
|||||
|
2023
Q1 | $19.7M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $13.1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $8.21M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $19.3M | Buy |
|
|||||
|
2020
Q1 | $8.4M | Sell |
|
|||||
|
2019
Q4 | $78.6M | Sell |
|
|||||
|
2019
Q3 | $63.3M | Buy |
|
|||||
|
2019
Q2 | $67.5M | Buy |
|
|||||
|
2019
Q1 | $88.2M | Sell |
|
|||||
|
2018
Q4 | $83M | Sell |
|
|||||
|
2018
Q3 | $159M | Buy |
|
|||||
|
2018
Q2 | $129M | Sell |
|
|||||
|
2018
Q1 | $332M | Buy |
|
|||||
|
2017
Q4 | $321M | Buy |
|
|||||
|
2017
Q3 | $256M | Buy |
|
|||||
|
2017
Q2 | $229M | Buy |
|
|||||
|
2017
Q1 | $147M | Buy |
|
|||||
|
2016
Q4 | $130M | Hold |
|
|||||
|
2016
Q3 | $143M | Sell |
|
|||||
|
2016
Q2 | $178M | Sell |
|
|||||
|
2016
Q1 | $192M | Buy |
|
|||||
|
2015
Q4 | $262M | Sell |
|
|||||
|
2015
Q3 | $227M | Buy |
|
|||||
|
2015
Q2 | $236M | Buy |
|
|||||
|
2015
Q1 | $190M | Buy |
|
|||||
|
2014
Q4 | $160M | Buy |
|
|||||
|
2014
Q3 | $133M | Buy |
|
|||||
|
2014
Q2 | $92.3M | Sell |
|
|||||
|
2014
Q1 | $162M | Sell |
|
|||||
|
2013
Q4 | $203M | Buy |
|
|||||
|
2013
Q3 | $161M | Buy |
|
|||||
|
2013
Q2 | $79M | Buy |
|